Modus Advisors, LLC Moderna, Inc. Transaction History

Modus Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 05, 2023	SELL	$118.5 - $160.53 $42,778 - $57,951	-361 Reduced 16.03%	1,891 $229,000
Q1 2023 Apr 04, 2023	SELL	$135.66 - $197.02 $949 - $1,379	-7 Reduced 0.31%	2,252 $345,000
Q3 2022 Oct 05, 2022	BUY	$118.07 - $194.18 $15,231 - $25,049	129 Added 6.06%	2,259 $267,000
Q2 2022 Jul 05, 2022	BUY	$117.13 - $176.59 $249,486 - $376,136	2,130 New	2,130 $304,000
Q3 2021 Oct 08, 2021	SELL	$221.9 - $484.47 $443 - $968	-2 Closed	0 $0
Q2 2021 Jul 01, 2021	BUY	$129.91 - $234.98 $259 - $469	2 New	2 $0

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Modus Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Modus Advisors, LLC with notifications on news.